Trial Profile
Rotation for Optimal Targeting of Albuminuria and Treatment Evaluation
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 08 Oct 2021
Price :
$35
*
At a glance
- Drugs Empagliflozin (Primary) ; Linagliptin (Primary) ; Sulodexide (Primary) ; Telmisartan (Primary)
- Indications Proteinuria; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms ROTATE-1
- 11 Jul 2016 New trial record